-
Oct 22, 2024 | 
mondaq.com | David Cox |Delaney Durst |Lara Flatau |Angela Humphreys
In the healthcare mergers and acquisitions (M&A) market,
while deal volumes varied across different sectors, by and large
the sure and steady pace of deal volume in Q2 continued into Q3.
-
Oct 17, 2024 | 
mondaq.com | Angela Humphreys |Delaney Durst |Ben Kelly
Bass, Berry & Sims, Deloitte and Harris Williams proudly
co-hosted the 14th annual Health Care Investors
Conference (HCIC) on October 9 as an associated event of the
Nashville Healthcare Sessions conference.
The firm welcomed approximately 200 investors, company leaders,
professionals serving entrepreneurial healthcare, and others to the
HCIC at the Country Music Hall of Fame in downtown Nashville.
-
Oct 17, 2024 | 
jdsupra.com | Delaney Durst |Angela Humphreys |Ben Kelly
Bass, Berry & Sims, Deloitte and Harris Williams proudly co-hosted the 14th annual Health Care Investors Conference (HCIC) on October 9 as an associated event of the Nashville Healthcare Sessions conference. The firm welcomed approximately 200 investors, company leaders, professionals serving entrepreneurial healthcare, and others to the HCIC at the Country Music Hall of Fame in downtown Nashville.
-
Sep 30, 2024 | 
jdsupra.com | Delaney Durst |Lara Flatau |Angela Humphreys
On September 28, California Governor Newsom vetoed Assembly Bill 3129 (Bill), which would have created significant oversight of private investment in and management of certain healthcare transactions and arrangements in California. Had the Bill been signed into law, certain transactions between a private equity group or hedge fund and healthcare facilities, provider groups, and providers would have required notice to and/or consent from the California Attorney General.
-
Aug 15, 2024 | 
mondaq.com | Meredith Collins |David Cox |Angela Humphreys |Kris Kemp
Although the U.S. healthcare industry has weathered the storm
over the past couple of years, we may be reaching calmer waters in
the coming months. Dry powder held by U.S. private equity investors
has reached an all-time high, and with capital on the sideline
ready to deploy, pressure to get deals done is on the rise.
With that backdrop, navigating the healthcare M&A landscape
continues to be increasingly challenging, especially with an
ever-evolving regulatory landscape.
-
Jun 6, 2024 | 
mondaq.com | Angela Humphreys
Recent legislative and rulemaking activity at both the federal
and state levels, along with changes in certain deal dynamics, are
sure to impact physician practice transactions going forward. Below
is a list of five new issues physician practice owners should consider in advance of a transaction. Many of these items should be
addressed in advance of going to market or accepting indications of
interest from potential buyers.
-
May 31, 2024 | 
physicianspractice.com | Angela Humphreys
Recent legislative and rulemaking activity at both the federal and state levels, along with changes in certain deal dynamics, are sure to impact physician practice transactions going forward. Below is a list of five new issues physician practice owners should consider in advance of a transaction. Many of these items should be addressed in advance of going to market or accepting indications of interest from potential buyers.
-
May 13, 2024 | 
mondaq.com | Angela Humphreys |Jennifer Michael
BB
Bass, Berry & Sims
More
Bass, Berry & Sims is a national law firm with nearly 350 attorneys dedicated to delivering exceptional service to numerous publicly traded companies and Fortune 500 businesses in significant litigation and investigations, complex business transactions, and international regulatory matters.
-
May 8, 2024 | 
jdsupra.com | Angela Humphreys |Jennifer Michael
The recent Request for Information by the Federal Trade Commission (FTC), Department of Justice (DOJ) and Department of Health and Human Services (HHS) seeking input on the effects of private equity (PE) investment in the healthcare sector underscores the importance of an effective compliance program. The best way to limit your exposure as a PE firm is to avoid a compliance misstep in the first place.
-
Jan 16, 2024 | 
mondaq.com | Meredith Collins |David Cox |Michael Hess |Angela Humphreys
The 42nd annual J.P. Morgan Healthcare Conference started with
clear skies and overall optimism from investors. But with Jamie
Dimon's prediction of a recession in 2024 on Tuesday morning,
the climate shifted to an on-again, off-again rain. Will this
dampen investors' outlook in 2024? This is what we heard:
With some large players having gone through restructurings and
Chapter 11 processes in 2023, it appears there are a number of
companies in the queue to follow suit in early 2024.
